Petros Pharmaceuticals Inc (PTPI)
0.6399
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.64
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Total Liabilities (Quarterly): 21.32M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.32M |
| September 30, 2023 | 31.86M |
| June 30, 2023 | 15.78M |
| March 31, 2023 | 15.12M |
| December 31, 2022 | 15.72M |
| September 30, 2022 | 17.00M |
| June 30, 2022 | 16.83M |
| Date | Value |
|---|---|
| March 31, 2022 | 20.14M |
| December 31, 2021 | 31.85M |
| September 30, 2021 | 34.19M |
| June 30, 2021 | 37.18M |
| March 31, 2021 | 45.23M |
| December 31, 2020 | 52.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.12M
Minimum
Mar 2023
52.38M
Maximum
Dec 2020
27.28M
Average
21.32M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 13.69M |
| Spectral AI Inc | 10.88M |
| Imunon Inc | 8.530M |
| Assembly Biosciences Inc | 95.73M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.80M |
| Shareholders Equity (Quarterly) | 12.48M |
| Debt to Equity Ratio | 0.6421 |
| Current Ratio | 1.893 |
| Net Debt Paydown Yield | 7.82% |